Dexcom anticipates $5.20B-$5.25B 2026 revenue while authorizing another $1B buyback
Dexcom's $5.20B–$5.25B 2026 revenue guidance and new $1B buyback authorization drive the score.
What changed
Dexcom's $5.20B–$5.25B 2026 revenue guidance and new $1B buyback authorization drive the score.
Why it matters
Dexcom's $5.20B–$5.25B 2026 revenue guidance and new $1B buyback authorization drive the score. — impact context not separately stored; see What changed.
← Dashboard
Oct 30, 2026 01:42 AM ET